Neutral impactStocks
Top stocks in news: UltraTech, ESDS, Gland Pharma, RVNL, Priority, IEX, Power Grid, Cipla, WeWork
Business Today 6 hrs ago·4 Sept 2026, 2:25 am
Gland Pharma has announced that its wholly-owned subsidiary, Gland Pharma Singapore, has entered into a definitive agreement to acquire a majority stake in a specialty pharmaceutical company. This strategic move is intended to expand the group's footprint in the global market and diversify its product portfolio.
For investors, this development signals Gland Pharma's continued focus on long-term growth and international expansion. By acquiring a stake in a specialized firm, the company aims to strengthen its capabilities in niche therapeutic areas, which could drive future revenue streams.
Investors should monitor the completion of the regulatory approvals and the financial details of the deal. Keeping an eye on how this acquisition integrates into Gland Pharma's existing operations will be key to understanding its impact on the stock.
Excerpt from Business Today
Stocks like UltraTech, ESDS Software, Gland Pharma, RVNL, Priority Jewels, Power Grid, Cipla, WeWork, IEX, Max Health and more will be in the spotlight on Friday, September 04. Indian equity benchmark ended lower on Thursday led by muted global cues amid geopolitical tension and elevated bond yields. The BSE Sensex…Read the original at Business Today
Affected stocks
Neutral4 stocks
Gland Pharma
GLAND Neutral
₹2,907.90
POWERGRID
POWERGRID Neutral
—
IEX
IEX Neutral
—
RVNL
RVNL Neutral
—
Bull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.
Key takeaways
- Concerns Gland Pharma (GLAND).
- Category: Stocks.
- Also mentions POWERGRID, IEX, RVNL.
Why it matters
A routine update for Gland Pharma. Use the price and stock snapshot to gauge how the market is responding.
